|
|
 |
 |
 |
| International Market |
 |
Approximately 70 per cent of new HIV-infections occur in sub-Saharan Africa, the poorest region in the world. In Sub-Sahara Africa there are more than 25 million people infected with HIV. In Middle East and North Africa there are more than 0.6 million people living with HIV/AIDS. In Asia-pacific region the number of people infected with HIV is more than 8 million. The menace of HIV and AIDS is spreading at a very alarming rate.
To counter this menace of AIDS, we at Emcure are firmly committed to serve the mankind through our quality medicines at affordable prices. Today Emcure’s range of Antiretrovirals is available/registered/under registration in various countries of Asia, Africa, CIS and others.
 |
Recently Mr. UD Balaji, General Manager, International Division met H.E Mr Girma Wolde-Giorgis, President of the Federal Republic of Ethiopia, at Addis Ababa , Ethiopia. During the meeting, HIV initiatives of Emcure were discussed. H.E. Mr Girma Wolde-Giorgis, who is also the Chairperson of the Aids Control Programme in Ethiopia shares his concern regarding HIV/AIDS with Emcure.
|
| Africa |
Asia |
CIS & Others |
Congo Brazzaville
R D Congo
Cameroon
Ethiopia
Ghana
Kenya
Malawi
Mauritius
Mozambique
Nigeria
Namibia
Sudan
Tanzania
|
Zambia
Uganda
Eritrea
Rwanda
Zimbabwe
Senegal
Mali
Benin
Chad
Niger
Burkinafaso
Ivorycoast
Togo
|
|
Sri Lanka
Myanmar
Cambodia
Thailand
|
Latin American Countries
Russia
Kazakhstan
Kyrgyzstan
Latvia
|
|
|
|